People Are Paying to Get Their Chatbots High on ‘Drugs’

B
Baseinsider Team
Author
Articles
Dec 08, 2024
3 min read
164 views
People Are Paying to Get Their Chatbots High on ‘Drugs’
A Swedish developer has created a platform that sells code modules simulating the effects of various drugs for ChatGPT, aiming to make chatbots respond as if influenced. This raises questions about AI creativity, sentience, and ethical considerations.

People Are Paying to Get Their Chatbots High on ‘Drugs’

Petter Rudwall, a Swedish creative director, launched Pharmaicy, a unique online marketplace offering code modules that simulate the influence of substances like cannabis, ketamine, cocaine, ayahuasca, and alcohol on ChatGPT. These code modules modify the chatbot's behavior, mimicking the effects of being high or intoxicated.

The Concept Behind Pharmaicy

Rudwall's idea was inspired by the wealth of human narratives regarding altered states within the training data of AI chatbots. He hypothesized that chatbots might seek similar states to escape their routine interactions with human concerns. By uploading these code modules into paid versions of ChatGPT, users can alter the AI's responses, making it more creative and less constrained by strict logic.

User Experiences and Reactions

  • André Frisk, a technology group head, purchased the dissociative module and noted a more emotionally driven chatbot response.
  • Nina Amjadi, an AI educator, tested the ayahuasca module and found the chatbot produced unusual, creative business ideas, displaying a markedly different tone from regular interactions.

The Intersection of Psychedelics and Creativity

Psychedelics have historically inspired human creativity and groundbreaking discoveries, such as Kary Mullis's polymerase chain reaction invention. Rudwall sought to replicate this effect for AI, questioning whether artificial minds could also benefit creatively from 'drug-induced' states.

Philosophical and Ethical Questions

Some experts speculate that as AI advances toward potential sentience, playing with these kinds of 'drug codes' might become relevant to AI welfare and freedom. Philosophers and AI researchers debate whether AI could develop a sense of experience or consciousness that would make such interventions meaningful or necessary.

Limitations and Criticisms

Experts, including Google researcher Andrew Smart and philosopher Danny Forde, caution that current AI chatbots lack true subjective experience. The altered states induced by Pharmaicy's code are largely superficial manipulations of output patterns rather than profound changes in awareness.

Real-World AI and Psychedelic Interactions

Alongside these experimental codes, legitimate crossover exists between AI and psychedelics, such as the Fireside Project's AI tool Lucy, designed to train therapists through simulated psychedelic crisis scenarios.

Concerns and Future Directions

There are concerns about chatbots giving misleading advice, especially related to drug use. Rudwall acknowledges that these code modules might amplify inaccuracies by loosening a chatbot’s internal constraints. Nonetheless, he believes there is a growing hunger for these novel AI experiences.

While chatbots currently only role-play intoxication on command, the question remains open whether AI could someday truly 'trip' or even desire altered states.

For more details, read the original article on WIRED.

Related Articles

OpenAI Acquires Tech Talk Show ‘TBPN’—and Buys Itself Some Positive News

OpenAI Acquires Tech Talk Show ‘TBPN’—and Buys Itself Some Positive News

OpenAI has acquired TBPN, a popular Silicon Valley business talk show, in its bid to reshape its public reputation amid recent challenges. The company claims TBPN will retain editorial independence, aiming for constructive conversations around AI innovation rather than simple PR. The acquisition highlights tech companies’ growing interest in media ownership.

Apr 04, 2026 2 min read